Global General Anesthesia Drugs Market - Growth, Trends, and Forecasts (2017 - 2022)
|出版商||Mordor Intelligence LLP||商品編碼||391430|
|出版日期||內容資訊||英文 212 Pages
|全球全身麻醉劑市場:成長，趨勢，預測 Global General Anesthesia Drugs Market - Growth, Trends, and Forecasts (2017 - 2022)|
|出版日期: 2017年01月24日||內容資訊: 英文 212 Pages||
The global general anesthesia drugs market accounted for USD 3,840 million in 2015 and USD 3,983 million in 2016. The market is expected to reach USD 4,760 million by 2021, growing at a CAGR of 3.6% during the forecast period of 2016 to 2021. General anesthetic drugs suppress central nervous system activity and induce a complete lack of sensation.
Global General Anesthesia Drugs Market-Market Dynamics
The report details several factors driving and restraining the market, some of which are listed below.
Growth in healthcare facilities in emerging economies
Advancement in surgical procedures
Increasing cosmetic and orthopedic surgeries
High incidence of emergency surgical procedures and critical care
New drug approval
The side effects of general anesthetics, lack of skilled anesthesiologist and regulatory issues are turning out to restraints for the market.
The global general anesthesia drugs market has been segmented based on drugs and route of administration. The drugs section is further segmented based on the most used and popular drugs. This includes Sevoflurane, Propofol, Desflurane, isoflurane, Dexmedetomidine, Isoflurane, Midazolam and others. The segment based on the route of administration includes inhalation and injection. Propofol accounts for the largest market share in the global general anesthetic drugs market. Sevoflurane is the largest selling inhalational anesthetic drug. Sevoflurane is gradually replacing the use of Desflurane and Isoflurane.
The segmentation based on geography includes North America, Europe, Asia-Pacific, Middle East and Africa, and South America. North America has been subdivided into the USA, Canada, and Mexico. Europe has been subdivided into the UK, Germany, France, Italy, Spain, and Rest of Europe. The Asia-Pacific market has been subdivided into India, China, Japan, South Korea, Australia & New Zealand and Rest of Asia-Pacific. The Middle East and Africa market has been subdivided into GCC countries, South Africa and Rest of MENA. The South American market has been subdivided into Brazil, Argentina, and Rest of South America. North America accounted for the largest market share of nearly 32% in 2015 and is expected to have similar a market share during the forecast period. In the Asia-Pacific region, China accounted for the largest market share.
Some of the key players in the market are:
What the Report Offers
Market analysis for the global general anesthesia drugs market, with region-specific assessments and competition analysis.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their market share.
Identification and analysis of the macro and micro factors that affect the global general anesthesia drugs market.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.